BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31136925)

  • 1. A phase II study of carboplatin AUC-10 guided by positron emission tomography-defined metabolic response in metastatic seminoma.
    Shamash J; Syed R; Sarker SJ; Sarwar N; Sharma A; Mutsvangwa K; Coetzee C; Wilson P; Rustin GJ
    Eur J Cancer; 2019 Jul; 115():128-135. PubMed ID: 31136925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GETUG SEMITEP Trial: De-escalating Chemotherapy in Good-prognosis Seminoma Based on Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
    Loriot Y; Texier M; Culine S; Fléchon A; Thiery-Vuillemin A; Gravis G; Geoffrois L; Chevreau C; Gross-Goupil M; Barthelemy P; Bompas E; Mahammedi H; Laguerre B; Lacourtoisie SA; Helissey C; Ladoire S; Abraham C; Massard C; Grimaldi S; Fizazi K
    Eur Urol; 2022 Aug; 82(2):172-179. PubMed ID: 35599187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.
    Tookman L; Rashid S; Matakidou A; Phillips M; Wilson P; Ansell W; Jamal-Hanjani M; Chowdhury S; Harland S; Sarwar N; Oliver T; Powles T; Shamash J
    Acta Oncol; 2013 Jun; 52(5):987-93. PubMed ID: 22943385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carboplatin monotherapy in clinical stage I of seminoma. An acceptable alternative?].
    Nöst G; Lipsky H; Würnschimmel E
    Urologe A; 1998 Nov; 37(6):629-34. PubMed ID: 9887492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single agent carboplatin for CS IIA/B testicular seminoma. A phase II study of the German Testicular Cancer Study Group (GTCSG).
    Krege S; Boergermann C; Baschek R; Hinke A; Pottek T; Kliesch S; Dieckmann KP; Albers P; Knutzen B; Weinknecht S; Schmoll HJ; Beyer J; Ruebben H;
    Ann Oncol; 2006 Feb; 17(2):276-80. PubMed ID: 16254023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.
    Diminutto A; Basso U; Maruzzo M; Morelli F; De Giorgi U; Perin A; Fraccon AP; Lo Re G; Rizzi A; Sava T; Fornarini G; Valcamonico F; Zustovich F; Massari F; Zanardi E; Roma A; Zattoni F; Zagonel V
    Clin Genitourin Cancer; 2016 Apr; 14(2):e161-9. PubMed ID: 26775721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant treatment of clinical stage I seminoma: is a single course of carboplatin sufficient?
    Dieckmann KP; Brüggeboes B; Pichlmeier U; Küster J; Müllerleile U; Bartels H
    Urology; 2000 Jan; 55(1):102-6. PubMed ID: 10654903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboplatin and cyclophosphamide in the treatment of metastatic seminoma.
    Mardiak J; Sálek T; Sycova-Milá Z; Sufliarsky J; Baláz M; Koza I
    Neoplasma; 2000; 47(4):244-7. PubMed ID: 11043830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG).
    Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A
    World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late relapse of stage i seminoma following single-agent carboplatin.
    Raj S; Williams MV; Dixon AK; Robson J; Mazhar D
    Oncology; 2007; 73(5-6):419-21. PubMed ID: 18515983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant carboplatin treatment for seminoma clinical stage I.
    Dieckmann KP; Krain J; Küster J; Brüggeboes B
    J Cancer Res Clin Oncol; 1996; 122(1):63-6. PubMed ID: 8543595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone.
    Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA
    Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interim (18)F-Fluorodeoxyglucose Positron Emission Tomography for Early Metabolic Assessment of Response to Cisplatin, Etoposide, and Bleomycin Chemotherapy for Metastatic Seminoma: Clinical Value and Future Directions.
    Necchi A; Nicolai N; Alessi A; Miceli R; Giannatempo P; Raggi D; Tana S; Serafini G; Padovano B; Mariani L; Crippa F; Salvioni R
    Clin Genitourin Cancer; 2016 Jun; 14(3):249-54. PubMed ID: 26433626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.
    Aparicio J; Germà JR; García del Muro X; Maroto P; Arranz JA; Sáenz A; Barnadas A; Dorca J; Gumà J; Olmos D; Bastús R; Carles J; Almenar D; Sánchez M; Paz-Ares L; Satrústegui JJ; Mellado B; Balil A; López-Brea M; Sánchez A;
    J Clin Oncol; 2005 Dec; 23(34):8717-23. PubMed ID: 16260698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-agent carboplatin AUC10 in metastatic seminoma: A multi-centre UK study of 216 patients.
    Alifrangis C; Sharma A; Chowdhury S; Duncan S; Milic M; Gogbashian A; Agarwal S; Sahdev A; Wilson P; Harland S; Stoneham S; Lockley M; Rustin G; Oliver T; Berney D; Shamash J
    Eur J Cancer; 2022 Mar; 164():105-113. PubMed ID: 33041185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
    Ruf CG; Borck S; Anheuser P; Matthies C; Nestler T; Zecha H; Isbarn H; Dieckmann KP
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2335-2342. PubMed ID: 31286241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study: adjuvant single-agent carboplatin therapy for clinical stage I seminoma.
    Krege S; Kalund G; Otto T; Goepel M; Rübben H
    Eur Urol; 1997; 31(4):405-7. PubMed ID: 9187898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial.
    Oliver RT; Mason MD; Mead GM; von der Maase H; Rustin GJ; Joffe JK; de Wit R; Aass N; Graham JD; Coleman R; Kirk SJ; Stenning SP;
    Lancet; 2005 Jul 23-29; 366(9482):293-300. PubMed ID: 16039331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party.
    Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP;
    Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective multicentre study of carboplatin monotherapy for clinical stage I seminoma.
    Steiner H; Scheiber K; Berger AP; Rein P; Hobisch A; Aufderklamm J; Pilloni S; Stoehr B; Aigner F; Fritzer A; Zangerl F
    BJU Int; 2011 Apr; 107(7):1074-9. PubMed ID: 21438975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.